Table 2 Molecular interaction analysis: computed affinities between identified protein targets and candidate compounds.

From: Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate

Target (PDB ID)

Drug

(PubChem ID)

Predictive database

Binding energy (kcal/mol)

Action type

Clinical development activities

SHMT1 (1bj4)

Mimosine (440473)

DrugBank

-5.7

Inhibitor

Antineoplastic alanine-substituted pyridine

Experimental

Pemetrexed (135410875)

ChEMBL

-8.2

Inhibitor

Folate analog

Approved, Investigational

Leucovorin (135403648)

DGIdb

-7.1

Inhibitor

Folate analog

Approved

Irinotecan (60838)

DGIdb

-8.8

NA

Topoisomerase inhibitor

Approved, Investigational